Offer - Urjas Oil for just ₹ 1 X
Rasalect 0.5 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Parkinson's Disease.
Medical history of the patient along with age and gender determines the dosage of Rasalect 0.5 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Rasalect 0.5 Tablet as well, which are listed below. Normally, these side effects of Rasalect 0.5 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Rasalect 0.5 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Rasalect 0.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Rasalect 0.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rasalect 0.5 Tablet in conditions like Psychosis, Low Blood Pressure (Hypotension). Other contraindications of Rasalect 0.5 Tablet have been discussed in the sections ahead.
Drug reaction of Rasalect 0.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Rasalect 0.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rasalect 0.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rasalect 0.5 Tablet safe for pregnant women?
Rasalect can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rasalect right away. Take your doctor's advice before taking it again.
Is the use of Rasalect 0.5 Tablet safe during breastfeeding?
Rasalect should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Rasalect 0.5 Tablet on the Kidneys?
Rasalect has very mild side effects on the kidneys.
What is the effect of Rasalect 0.5 Tablet on the Liver?
Rasalect may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rasalect 0.5 Tablet on the Heart?
Using Rasalect does not have any harmful effects on the heart.
Rasalect 0.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rasalect 0.5 Tablet unless your doctor advises you to do so -
Is this Rasalect 0.5 Tablet habit forming or addictive?
No, you will not get addicted to Rasalect 0.5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Rasalect 0.5 Tablet. So it is best to avoid driving.
Is it safe?
Rasalect 0.5 Tablet is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Yes, in many cases, taking Rasalect 0.5 Tablet can help with mental disorders.
Interaction between Food and Rasalect 0.5 Tablet
Some foods when eaten with Rasalect 0.5 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Rasalect 0.5 Tablet
Taking alcohol with Rasalect 0.5 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086